Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Noam VanderWalde MD

Noam VanderWalde MD

Assistant Professor, Department of Radiation Oncology, University of Tennessee West Cancer Clinic, Memphis, Tennessee

Dr. VanderWalde is an Assistant Professor in the department of radiation oncology at the University of Tennessee West Cancer Center. He’s previous research interests included work in pediatric, geriatric and radiation oncology. He has several  health services related  research publications in the field of head and neck cancer. He is now pursuing an academic career focused on clinical and health services outcomes research in radiation oncology with a focus on geriatrics.  

Recent Contributions to PracticeUpdate:

  1. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers
  2. Hypofractionated Breast Radiotherapy for 1 Week Noninferior to 3 Weeks
  3. Single-Fraction High-Gradient Adjuvant Partial Breast Irradiation for Hormone-Sensitive Early-Stage Breast Cancer
  4. Accelerated Partial Breast Irradiation After Breast-Conserving Surgery for Early-Stage Breast Cancer
  5. External Beam Accelerated Partial Breast Irradiation vs Whole Breast Irradiation After Breast-Conserving Surgery in Women With DCIS or Node-Negative Breast Cancer
  6. Stereotactic Ablative Radiotherapy vs Standard of Care Palliative Treatment in Patients With Oligometastatic Cancers
  7. Stereotactic Radiation Feasible for Oligometastatic Cancer
  8. Noninferiority of Partial-Breast and Reduced-Dose Radiotherapy After Breast Conservation Surgery for Patients With Early Breast Cancer
  9. Estimating the Risks of Breast Cancer Radiotherapy
  10. Predictive Model for Chemotherapy Toxicity

Most Read This Week

Recently Updated